With regard to the Canadian Institutes of Health Research (CIHR) and its funding of the study titled “Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission”: (a) to what funding opportunity stream, and what application criteria, did Fisman et al. submit their grant application and receive funding approval; (b) when CIHR conducted a peer review of this application prior to funding, (i) which researchers were assigned to conduct this review, (ii) what were their qualifications, (iii) what were their conclusions, (iv) what were their conflicts of interest; (c) how much funding did CIHR grant this study project; (d) were there any other funding agencies or entities supporting this study; (e) if the answer to (d) is affirmative, who were the other funding agencies or entities; (f) what was the expected timeline for study completion at the time of funding; (g) what conflicts of interest were listed for the grant applicants at the time of funding; (h) was there any federal government involvement with, or communication regarding, any component of the application review process, research study, or media outreach; (i) if the answer to (h) is affirmative, which government bodies were involved; (j) what are the details of the media communications once the study was completed, broken down by (i) subject, (ii) type of communication, (iii) who directed the communication, (iv) date of communication; (k) after the study was published, did CIHR receive any negative feedback; (l) if the answer to (k) is affirmative, (i) what was that feedback, (ii) how was it addressed; (m) what is CIHR’s average timeline from the day a grant application is received to when the grant is approved; and (n) what was the timeline from the day the grant application was received to when the funding approval decision was made for the above-captioned study?
In the House of Commons on May 6th, 2024. See this statement in context.